HighTide Therapeutics, Inc. (HTTIF)

OTCMKTS · Delayed Price · Currency is USD

0.3893

0.00 (0.00%)

Mar 10, 2026, 12:52 PM EST

Market Cap	267.98M +14.7%
Revenue (ttm)	n/a
Net Income	-35.02M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.3893
Previous Close	0.3893
Day's Range	0.3893 - 0.3893
52-Week Range	0.3358 - 0.4883
Beta	-0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About HighTide Therapeutics

HighTide Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China. Its lead drug candidate is HTD1801, which is in phase III clinical trial to treat type 2 diabetes mellitus (T2DM); in phase I clinical trial to treat gradual loss of kidney function over time; phase IIb for the treatment of pathogenetic complexity and heterogeneity; phase I to treat obesity; and phase II for the treatment of chronic cholestatic liver disea... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2011

Country Cayman Islands

Stock Exchange OTCMKTS

Ticker Symbol HTTIF

Financial Performance

Financial numbers in CNY Financial Statements